We are live on ! Find out more
IROQ

IF Bancorp

Delisted

IROQ was delisted on the 12th of March, 2026.

17 hedge funds and large institutions have $16.6M invested in IF Bancorp in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

8% more capital invested

Capital invested by funds: $15.4M → $16.6M (+$1.21M)

1.47% more ownership

Funds ownership: 20.54%22.01% (+1.5%)

11% less funds holding

Funds holding: 1917 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
6
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change

IROQ Hedge Fund Activity: Q4 2019 in Review

17 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in IF Bancorp (IROQ) for Q4 2019, worth a combined $16.6M — up 7.9% from $15.4M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of IROQ and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 6 added.

The largest buyer was Gendell Jeffrey L, adding an estimated $210K. The largest seller was Beese Fulmer Investment Management, exiting entirely with an estimated $418K sold.

  • 17 institutional investors held IF Bancorp (IROQ) as of Q4 2019, down from 19 in Q3 2019.
  • Funds reported $16.6M of IF Bancorp stock for Q4 2019, up 7.9% quarter-over-quarter.
  • 1 fund opened new IF Bancorp positions in Q4 2019 and 3 closed out, a net change of -2 holders.
  • The largest IF Bancorp buyer in Q4 2019 was Gendell Jeffrey L, an estimated $210K added.
  • The largest IF Bancorp seller in Q4 2019 was Beese Fulmer Investment Management, an estimated $418K sold.

Based on aggregated 13F filings for Q4 2019.